Trial intelligence / Profile preview

Effect of 17α-hydroxyprogesterone caproate on prevention of preterm labor

IRCT20190309042978N2Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of hydroxyprogesterone caproate in Preterm labor (PTL), sponsored by Mazandaran University of Medical Sciences. Started Mar 2019; status: completed.

02

Drugs

hydroxyprogesterone caproate
03

Conditions

Preterm labor (PTL)

Beyond the preview

Go deeper on IRCT20190309042978N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190309042978N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call